P 
Profarma Distribuidora de Produtos Farmaceuticos PFRM3.SA · BRL
Health Care · B3 · 🇧🇷 Brazil
7.22
+2.12%
Close of 9 Nov 2026, in BRL
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in BRL, from our data supplier.
Revenue
BRL 11.45bn
FY2016FY2025
Net income
BRL 118.9m
FY2016FY2025
Free cash flow
BRL 190.2m
FY2016FY2025
Shareholders' equity
BRL 1.35bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | BRL 11.45bn | BRL 10.15bn | BRL 8.66bn | BRL 7.82bn | BRL 6.41bn | BRL 5.48bn | BRL 4.80bn | BRL 4.27bn | BRL 4.10bn | BRL 4.08bn |
| Gross profit | BRL 1.75bn | BRL 1.52bn | BRL 1.29bn | BRL 1.15bn | BRL 907.6m | BRL 763.6m | BRL 737.8m | BRL 680.9m | BRL 701.0m | BRL 625.3m |
| Research and development | — | — | — | — | — | — | — | BRL 61,000 | — | — |
| Operating income | BRL 381.6m | BRL 254.3m | BRL 204.8m | BRL 243.2m | BRL 109.1m | BRL 97.2m | BRL 72.8m | BRL 75.3m | BRL 48.1m | BRL 120.5m |
| Net income | BRL 118.9m | BRL 114.6m | BRL 70.4m | BRL 80.9m | BRL 78.2m | BRL 52.3m | BRL 12.0m | −BRL 9.7m | −BRL 112.7m | −BRL 49.0m |
| Diluted earnings per share | 0.97 | 0.93 | 0.57 | 0.65 | 0.64 | 0.43 | 0.10 | -0.08 | -1.48 | -0.76 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | BRL 6.23bn | BRL 5.62bn | BRL 4.94bn | BRL 4.36bn | BRL 4.03bn | BRL 3.76bn | BRL 3.18bn | BRL 2.89bn | BRL 2.62bn | BRL 2.71bn |
| Cash and short-term investments | BRL 235.1m | BRL 229.6m | BRL 193.7m | BRL 183.3m | BRL 188.5m | BRL 371.8m | BRL 230.3m | BRL 238.1m | BRL 193.2m | BRL 205.5m |
| Total liabilities | BRL 4.60bn | BRL 4.03bn | BRL 3.40bn | BRL 2.85bn | BRL 2.56bn | BRL 2.33bn | BRL 2.18bn | BRL 1.87bn | BRL 1.87bn | BRL 1.95bn |
| Debt | BRL 1.40bn | BRL 1.25bn | BRL 1.14bn | BRL 1.02bn | BRL 946.9m | BRL 900.7m | BRL 897.4m | BRL 636.0m | BRL 757.2m | BRL 608.7m |
| Shareholders' equity | BRL 1.35bn | BRL 1.30bn | BRL 1.25bn | BRL 1.19bn | BRL 1.09bn | BRL 1.05bn | BRL 1.00bn | BRL 1.02bn | BRL 745.9m | BRL 759.0m |
| Shares outstanding | 123m | 123m | 123m | 124m | 123m | 123m | 123m | 123m | 76m | 65m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | BRL 336.9m | BRL 497.1m | BRL 260.9m | BRL 126.3m | BRL 107.6m | BRL 39.3m | BRL 127.6m | −BRL 55.8m | −BRL 51.8m | −BRL 107.3m |
| Capital spending | −BRL 146.7m | −BRL 28.1m | −BRL 14.0m | −BRL 10.5m | −BRL 13.5m | −BRL 36.0m | −BRL 27.4m | −BRL 15.6m | −BRL 51.5m | −BRL 29.5m |
| Free cash flow | BRL 190.2m | BRL 469.0m | BRL 246.9m | BRL 115.8m | BRL 94.0m | BRL 3.3m | BRL 100.2m | −BRL 71.4m | −BRL 103.3m | −BRL 136.7m |
| Dividends paid | −BRL 76.7m | −BRL 54.6m | −BRL 31.2m | — | −BRL 29.1m | −BRL 29.1m | −BRL 29.1m | −BRL 29.1m | — | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | BRL 3.58bn | BRL 2.87bn | BRL 3.19bn | BRL 2.85bn | BRL 2.70bn | BRL 2.71bn | BRL 3.02bn | BRL 2.60bn |
| Gross profit | BRL 533.6m | BRL 434.4m | BRL 475.3m | BRL 447.0m | BRL 434.0m | BRL 394.1m | BRL 413.7m | BRL 395.6m |
| Operating income | BRL 126.3m | BRL 59.1m | BRL 87.0m | BRL 87.7m | BRL 97.8m | BRL 34.5m | BRL 56.8m | BRL 86.2m |
| Net income | BRL 70.8m | −BRL 1.8m | BRL 38.8m | BRL 46.7m | BRL 21.8m | BRL 11.7m | BRL 35.5m | BRL 49.0m |
| Diluted earnings per share | 0.58 | -0.01 | 0.32 | 0.38 | 0.18 | 0.10 | 0.29 | 0.40 |
| Cash from operations | −BRL 22.0m | −BRL 1.0m | BRL 71.0m | BRL 413.0m | −BRL 67.0m | — | BRL 85.0m | BRL 335.0m |
| Capital spending | −BRL 43.0m | −BRL 25.0m | −BRL 56.0m | −BRL 36.0m | −BRL 32.0m | −BRL 24.0m | −BRL 41.0m | −BRL 26.0m |
| Free cash flow | −BRL 65.0m | −BRL 26.0m | BRL 15.0m | BRL 377.0m | −BRL 99.0m | — | BRL 44.0m | BRL 309.0m |
| Total assets | BRL 7.98bn | BRL 6.04bn | BRL 6.23bn | BRL 5.64bn | BRL 5.37bn | BRL 5.79bn | BRL 5.62bn | BRL 5.12bn |
| Cash and short-term investments | BRL 487.8m | BRL 316.5m | BRL 235.1m | BRL 263.5m | BRL 246.6m | BRL 265.9m | BRL 229.6m | BRL 231.3m |
| Debt | BRL 1.46bn | BRL 1.18bn | BRL 1.52bn | BRL 1.42bn | BRL 1.69bn | BRL 1.43bn | BRL 1.25bn | BRL 1.17bn |
| Shareholders' equity | BRL 1.44bn | BRL 1.34bn | BRL 1.35bn | BRL 1.39bn | BRL 1.34bn | BRL 1.32bn | BRL 1.30bn | BRL 1.34bn |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 13.6% | 15.9% | 12.7% |
| Operating income | 16.2% | 31.5% | 17.0% |
| Net income | 13.7% | 17.8% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 15.2% | 15.0% | 14.8% | 14.9% |
| Operating margin | 2.9% | 2.8% | 2.6% | 2.4% |
| Net margin | 1.1% | 1.0% | 1.0% | 0.5% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 8.9 | 6.9 | 10.6 | 5.6 | 9.3 | 14.3 | 66.2 | -49.5 | -4.8 | -10.4 |
| Price to sales | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 |
Dividends and splits
Per share, in the currency the company pays
Paid for 5 years. Last went ex-dividend on 2 Jan 2026.
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2014 | FY2013 | FY2012 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.644 | 0.575 | 0.386 | 0.173 | 0.271 | 0.126 | 0.186 | 0.127 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.